Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

Editorial

  • Editorial
    Taming Clinical Research's Paper Tigers
    John I. Gallin
    Clin Cancer Res July 15 2006 12 (14) 4131-4131; DOI:10.1158/1078-0432.CCR-06-1095

The Biology Behind

  • The Biology Behind
    Selective TRAIL-Induced Apoptosis in Dysplastic Neoplasia of the Colon May Lead to New Neoadjuvant or Adjuvant Therapies
    Niklas Finnberg and Wafik S. El-Deiry
    Clin Cancer Res July 15 2006 12 (14) 4132-4136; DOI:10.1158/1078-0432.CCR-06-0567

CCR Drug Updates

  • CCR Drug Updates
    Genetic Testing in Cancer Therapeutics
    Hany H. Ezzeldin and Robert B. Diasio
    Clin Cancer Res July 15 2006 12 (14) 4137-4141; DOI:10.1158/1078-0432.CCR-06-0707

Molecular Pathways

  • Molecular Pathways
    Inhibition of Transforming Growth Factor-β Signaling in Human Cancer: Targeting a Tumor Suppressor Network as a Therapeutic Strategy
    Swati Biswas, Tracy L. Criswell, Shizhen Emily Wang and Carlos L. Arteaga
    Clin Cancer Res July 15 2006 12 (14) 4142-4146; DOI:10.1158/1078-0432.CCR-06-0952

Review

  • Review
    Chronic Oxaliplatin Resistance Induces Epithelial-to-Mesenchymal Transition in Colorectal Cancer Cell Lines
    Anthony D. Yang, Fan Fan, E. Ramsay Camp, George van Buren, Wenbiao Liu, Ray Somcio, Michael J. Gray, Haiyun Cheng, Paulo M. Hoff and Lee M. Ellis
    Clin Cancer Res July 15 2006 12 (14) 4147-4153; DOI:10.1158/1078-0432.CCR-06-0038

Human Cancer Biology

  • Human Cancer Biology
    c-Met Ectodomain Shedding Rate Correlates with Malignant Potential
    Gagani Athauda, Alessio Giubellino, Jonathan A. Coleman, Christine Horak, Patricia S. Steeg, Ming-Jung Lee, Jane Trepel, Jennifer Wimberly, Jan Sun, Angela Coxon, Teresa L. Burgess and Donald P. Bottaro
    Clin Cancer Res July 15 2006 12 (14) 4154-4162; DOI:10.1158/1078-0432.CCR-06-0250

  • Human Cancer Biology
    Unexpected Abundance of HLA Class II Presented Peptides in Primary Renal Cell Carcinomas
    Jörn Dengjel, Maria-Dorothea Nastke, Cécile Gouttefangeas, Gitsios Gitsioudis, Oliver Schoor, Florian Altenberend, Margret Müller, Björn Krämer, Anna Missiou, Martina Sauter, Jörg Hennenlotter, Dorothee Wernet, Arnulf Stenzl, Hans-Georg Rammensee, Karin Klingel and Stefan Stevanović
    Clin Cancer Res July 15 2006 12 (14) 4163-4170; DOI:10.1158/1078-0432.CCR-05-2470

  • Human Cancer Biology
    Hypomethylated P4 Promoter Induces Expression of the Insulin-Like Growth Factor-II Gene in Hepatocellular Carcinoma in a Chinese Population
    Shao Hui Tang, Dong Hua Yang, Wei Huang, Hong Ke Zhou, Xiao Hua Lu and Gang Ye
    Clin Cancer Res July 15 2006 12 (14) 4171-4177; DOI:10.1158/1078-0432.CCR-05-2261

  • Human Cancer Biology
    Isolation of Human Prostatic Epithelial Plasma Membranes for Proteomics Using Mirror Image Tissue Banking of Radical Prostatectomy Specimens
    Kanishka Sircar, Louis Gaboury, Lydia Ouadi, Melanie Mecteau, Eleonora Scarlata, Fred Saad, Armen Aprikian, Simon Tanguay, Steven Lapointe, Christian Lussier, Tina Miletti and Joel Lanoix
    Clin Cancer Res July 15 2006 12 (14) 4178-4184; DOI:10.1158/1078-0432.CCR-06-0328

  • Human Cancer Biology
    Basoluminal Carcinoma: A New Biologically and Prognostically Distinct Entity Between Basal and Luminal Breast Cancer
    Mervi Laakso, Minna Tanner, Jonas Nilsson, Tom Wiklund, Björn Erikstein, Pirkko Kellokumpu-Lehtinen, Per Malmström, Nils Wilking, Jonas Bergh and Jorma Isola
    Clin Cancer Res July 15 2006 12 (14) 4185-4191; DOI:10.1158/1078-0432.CCR-06-0353

  • Human Cancer Biology
    PC Cell–Derived Growth Factor Stimulates Proliferation and Confers Trastuzumab Resistance to Her-2-Overexpressing Breast Cancer Cells
    Wes E. Kim and Ginette Serrero
    Clin Cancer Res July 15 2006 12 (14) 4192-4199; DOI:10.1158/1078-0432.CCR-05-2663

  • Human Cancer Biology
    Peroxisome Proliferator-Activated Receptor γ and Growth Inhibition by Its Ligands in Uterine Endometrial Carcinoma
    Kyoko Ota, Kiyoshi Ito, Takashi Suzuki, Sumika Saito, Mitsutoshi Tamura, Shin-ichi Hayashi, Kunihiro Okamura, Hironobu Sasano and Nobuo Yaegashi
    Clin Cancer Res July 15 2006 12 (14) 4200-4208; DOI:10.1158/1078-0432.CCR-05-1833

Imaging, Diagnosis, Prognosis

  • Imaging, Diagnosis, Prognosis
    Electron Paramagnetic Resonance Oxygen Images Correlate Spatially and Quantitatively with Oxylite Oxygen Measurements
    Martyna Elas, Kang-Hyun Ahn, Adrian Parasca, Eugene D. Barth, David Lee, Chad Haney and Howard J. Halpern
    Clin Cancer Res July 15 2006 12 (14) 4209-4217; DOI:10.1158/1078-0432.CCR-05-0446

  • Imaging, Diagnosis, Prognosis
    Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival
    Daniel F. Hayes, Massimo Cristofanilli, G. Thomas Budd, Matthew J. Ellis, Alison Stopeck, M. Craig Miller, Jeri Matera, W. Jeffrey Allard, Gerald V. Doyle and Leon W.W.M. Terstappen
    Clin Cancer Res July 15 2006 12 (14) 4218-4224; DOI:10.1158/1078-0432.CCR-05-2821

  • Imaging, Diagnosis, Prognosis
    Megakaryocyte Potentiation Factor Cleaved from Mesothelin Precursor Is a Useful Tumor Marker in the Serum of Patients with Mesothelioma
    Masanori Onda, Satoshi Nagata, Mitchell Ho, Tapan K. Bera, Raffit Hassan, Richard H. Alexander and Ira Pastan
    Clin Cancer Res July 15 2006 12 (14) 4225-4231; DOI:10.1158/1078-0432.CCR-06-0472

  • Imaging, Diagnosis, Prognosis
    High Fluorodeoxyglucose Uptake on Positron Emission Tomography in Patients with Advanced Non–Small Cell Lung Cancer on Platinum-Based Combination Chemotherapy
    Kyung-Hun Lee, Se-Hoon Lee, Dong-Wan Kim, Won Jun Kang, June-Key Chung, Seock-Ah Im, Tae-You Kim, Young Whan Kim, Yung-Jue Bang and Dae Seog Heo
    Clin Cancer Res July 15 2006 12 (14) 4232-4236; DOI:10.1158/1078-0432.CCR-05-2710

  • Imaging, Diagnosis, Prognosis
    High WT1 Expression Is Associated with Very Poor Survival of Patients with Osteogenic Sarcoma Metastasis
    Alok Srivastava, Bruno Fuchs, Kunbo Zhang, Ming Ruan, Chandralekha Halder, Eric Mahlum, Kristin Weber, Mark E. Bolander and Gobinda Sarkar
    Clin Cancer Res July 15 2006 12 (14) 4237-4243; DOI:10.1158/1078-0432.CCR-05-2307

  • Imaging, Diagnosis, Prognosis
    Inverse Effects of Mucin on Survival of Matched Hereditary Nonpolyposis Colorectal Cancer and Sporadic Colorectal Cancer Patients
    Jeng-Fu You, Ling-Ling Hsieh, Chung Rong Changchien, Jinn-Shiun Chen, Jim-Ray Chen, Jy-Ming Chiang, Chien Yuh Yeh, Pao-Shiu Hsieh, Chung-Wei Fan, Chun-Ting Liu and Reiping Tang
    Clin Cancer Res July 15 2006 12 (14) 4244-4250; DOI:10.1158/1078-0432.CCR-06-0202

  • Imaging, Diagnosis, Prognosis
    An Immunohistochemical Study of Morules in Endometrioid Lesions of the Female Genital Tract: CD10 Is a Characteristic Marker of Morular Metaplasia
    Silvia Chiarelli, Catalina Buriticá, Piero Litta, Susana Ciani, Rosa Guarch and Francisco F. Nogales
    Clin Cancer Res July 15 2006 12 (14) 4251-4256; DOI:10.1158/1078-0432.CCR-06-0398

  • Imaging, Diagnosis, Prognosis
    MUC4 Is a Novel Prognostic Factor of Extrahepatic Bile Duct Carcinoma
    Shugo Tamada, Hiroaki Shibahara, Michiyo Higashi, Masamichi Goto, Surinder K. Batra, Kohzoh Imai and Suguru Yonezawa
    Clin Cancer Res July 15 2006 12 (14) 4257-4264; DOI:10.1158/1078-0432.CCR-05-2814

Cancer Therapy: Clinical

  • Cancer Therapy: Clinical
    Clinical and Biological Effects of Recombinant Human Interleukin-18 Administered by Intravenous Infusion to Patients with Advanced Cancer
    Michael J. Robertson, James W. Mier, Theodore Logan, Michael Atkins, Henry Koon, Kevin M. Koch, Steven Kathman, Lini N. Pandite, Coreen Oei, Lyndon C. Kirby, Roxanne C. Jewell, William N. Bell, Linda M. Thurmond, Jill Weisenbach, Suzanne Roberts and Mohammed M. Dar
    Clin Cancer Res July 15 2006 12 (14) 4265-4273; DOI:10.1158/1078-0432.CCR-06-0121

  • Cancer Therapy: Clinical
    A Phase I Clinical and Pharmacokinetic Study of Oral CI-1033 in Combination with Docetaxel in Patients with Advanced Solid Tumors
    Linda L. Garland, Manuel Hidalgo, David S. Mendelson, David P. Ryan, Banu K. Arun, Jennifer L. Lovalvo, Irene A. Eiseman, Stephen C. Olson, Peter F. Lenehan and Joseph P. Eder
    Clin Cancer Res July 15 2006 12 (14) 4274-4282; DOI:10.1158/1078-0432.CCR-05-2507

  • Cancer Therapy: Clinical
    Epidermal Growth Factor Receptor Kinase Domain Mutations in Esophageal and Pancreatic Adenocarcinomas
    Eunice L. Kwak, Janusz Jankowski, Sarah P. Thayer, Gregory Y. Lauwers, Brian W. Brannigan, Patricia L. Harris, Ross A. Okimoto, Sara M. Haserlat, David R. Driscoll, David Ferry, Beth Muir, Jeff Settleman, Charles S. Fuchs, Matthew H. Kulke, David P. Ryan, Jeff W. Clark, Dennis C. Sgroi, Daniel A. Haber and Daphne W. Bell
    Clin Cancer Res July 15 2006 12 (14) 4283-4287; DOI:10.1158/1078-0432.CCR-06-0189

Cancer Therapy: Preclinical

  • Cancer Therapy: Preclinical
    The Synthetic Triterpenoid CDDO-Imidazolide Suppresses STAT Phosphorylation and Induces Apoptosis in Myeloma and Lung Cancer Cells
    Karen Liby, Nga Voong, Charlotte R. Williams, Renee Risingsong, Darlene B. Royce, Tadashi Honda, Gordon W. Gribble, Michael B. Sporn and John J. Letterio
    Clin Cancer Res July 15 2006 12 (14) 4288-4293; DOI:10.1158/1078-0432.CCR-06-0215

  • Cancer Therapy: Preclinical
    Systemic Anti-CD25 Monoclonal Antibody Administration Safely Enhances Immunity in Murine Glioma without Eliminating Regulatory T Cells
    Peter E. Fecci, Alison E. Sweeney, Peter M. Grossi, Smita K. Nair, Christopher A. Learn, Duane A. Mitchell, Xiuyu Cui, Thomas J. Cummings, Darell D. Bigner, Eli Gilboa and John H. Sampson
    Clin Cancer Res July 15 2006 12 (14) 4294-4305; DOI:10.1158/1078-0432.CCR-06-0053

  • Cancer Therapy: Preclinical
    Xenografts of Human Hepatocellular Carcinoma: A Useful Model for Testing Drugs
    Hung Huynh, Khee Chee Soo, Pierce K.H. Chow, Lawrence Panasci and Evelyn Tran
    Clin Cancer Res July 15 2006 12 (14) 4306-4314; DOI:10.1158/1078-0432.CCR-05-2568

  • Cancer Therapy: Preclinical
    Inhibition of Growth and Metastasis of Mouse Mammary Carcinoma by Selective Inhibitor of Transforming Growth Factor-β Type I Receptor Kinase In vivo
    Rongrong Ge, Vaishali Rajeev, Partha Ray, Edmund Lattime, Susan Rittling, Satya Medicherla, Andy Protter, Alison Murphy, Jit Chakravarty, Sundeep Dugar, George Schreiner, Nicola Barnard and Michael Reiss
    Clin Cancer Res July 15 2006 12 (14) 4315-4330; DOI:10.1158/1078-0432.CCR-06-0162

  • Cancer Therapy: Preclinical
    Influence of Formulation Vehicle on Metronomic Taxane Chemotherapy: Albumin-Bound versus Cremophor EL–Based Paclitaxel
    Sylvia S.W. Ng, Alex Sparreboom, Yuval Shaked, Christina Lee, Shan Man, Neil Desai, Patrick Soon-Shiong, William D. Figg and Robert S. Kerbel
    Clin Cancer Res July 15 2006 12 (14) 4331-4338; DOI:10.1158/1078-0432.CCR-05-2762

  • Cancer Therapy: Preclinical
    Overcoming Drug-Resistant Cancer by a Newly Developed Copper Chelate through Host-Protective Cytokine-Mediated Apoptosis
    Ananda Mookerjee, Jayati Mookerjee Basu, Pranabananda Dutta, Surajit Majumder, Sankar Bhattacharyya, Jaydip Biswas, Smarajit Pal, Pratima Mukherjee, Sanghamitra Raha, Rathindra N. Baral, Tania Das, Thomas Efferth, Gourisankar Sa, Shyamal Roy and Soumitra K. Choudhuri
    Clin Cancer Res July 15 2006 12 (14) 4339-4349; DOI:10.1158/1078-0432.CCR-06-0001

  • Cancer Therapy: Preclinical
    TRAIL Induces Apoptosis in Human Colorectal Adenoma Cell Lines and Human Colorectal Adenomas
    Mathilde Jalving, Steven de Jong, Jan J. Koornstra, Wytske Boersma-van Ek, Nynke Zwart, Jelle Wesseling, Elisabeth G.E. de Vries and Jan H. Kleibeuker
    Clin Cancer Res July 15 2006 12 (14) 4350-4356; DOI:10.1158/1078-0432.CCR-05-2487

  • Cancer Therapy: Preclinical
    ABCA3 as a Possible Cause of Drug Resistance in Childhood Acute Myeloid Leukemia
    Daniel Steinbach, Jean-Pierre Gillet, Axel Sauerbrey, Bernd Gruhn, Kristin Dawczynski, Vincent Bertholet, Françoise de Longueville, Felix Zintl, Jose Remacle and Thomas Efferth
    Clin Cancer Res July 15 2006 12 (14) 4357-4363; DOI:10.1158/1078-0432.CCR-05-2587

Correction

  • Correction
    Article on Mesenchymal Stem Cell Targeting of Microscopic Tumors
    Clin Cancer Res July 15 2006 12 (14) 4364-4364; DOI:10.1158/1078-0432.CCR-12-14-COR

Novel Agents in the Treatment of Lung Cancer: Advances in EGFR-Targeted Agents

  • Novel Agents in the Treatment of Lung Cancer: Advances in EGFR-Targeted Agents
    Summary Statement: Novel Agents in the Treatment of Lung Cancer: Advances in Epidermal Growth Factor Receptor-Targeted Agents
    Thomas J. Lynch, Alex A. Adjei, Paul A. Bunn Jr., Tim G. Eisen, Jeffrey Engelman, Glenwood D. Goss, Daniel A. Haber, John V. Heymach, Pasi A. Jänne, Bruce E. Johnson, David H. Johnson, Rogerio C. Lilenbaum, Matthew Meyerson, Alan B. Sandler, Lecia V. Sequist, Jeffrey Settleman, Kwok-Kin Wong and Carol S. Hart
    Clin Cancer Res July 15 2006 12 (14) 4365s-4371s; DOI:10.1158/1078-0432.CCR-06-1005

  • Novel Agents in the Treatment of Lung Cancer: Advances in EGFR-Targeted Agents
    The Role of the ErbB Family Members in Non–Small Cell Lung Cancers Sensitive to Epidermal Growth Factor Receptor Kinase Inhibitors
    Jeffrey A. Engelman and Lewis C. Cantley
    Clin Cancer Res July 15 2006 12 (14) 4372s-4376s; DOI:10.1158/1078-0432.CCR-06-0795

  • Novel Agents in the Treatment of Lung Cancer: Advances in EGFR-Targeted Agents
    Her2-Targeted Therapies in Non–Small Cell Lung Cancer
    Charles Swanton, Andy Futreal and Tim Eisen
    Clin Cancer Res July 15 2006 12 (14) 4377s-4383s; DOI:10.1158/1078-0432.CCR-06-0115

  • Novel Agents in the Treatment of Lung Cancer: Advances in EGFR-Targeted Agents
    Genomic Approaches to Lung Cancer
    Roman K. Thomas, Barbara Weir and Matthew Meyerson
    Clin Cancer Res July 15 2006 12 (14) 4384s-4391s; DOI:10.1158/1078-0432.CCR-06-0098

  • Novel Agents in the Treatment of Lung Cancer: Advances in EGFR-Targeted Agents
    “Oncogenic Shock”: Explaining Oncogene Addiction through Differential Signal Attenuation
    Sreenath V. Sharma, Michael A. Fischbach, Daniel A. Haber and Jeffrey Settleman
    Clin Cancer Res July 15 2006 12 (14) 4392s-4395s; DOI:10.1158/1078-0432.CCR-06-0096

  • Novel Agents in the Treatment of Lung Cancer: Advances in EGFR-Targeted Agents
    Mouse Models of Lung Cancer
    Amit Dutt and Kwok-Kin Wong
    Clin Cancer Res July 15 2006 12 (14) 4396s-4402s; DOI:10.1158/1078-0432.CCR-06-0414

  • Novel Agents in the Treatment of Lung Cancer: Advances in EGFR-Targeted Agents
    Epidermal Growth Factor Receptor Mutation Testing in the Care of Lung Cancer Patients
    Lecia V. Sequist, Victoria A. Joshi, Pasi A. Jänne, Daphne W. Bell, Panos Fidias, Neal I. Lindeman, David N. Louis, Jeffrey C. Lee, Eugene J. Mark, Janina Longtine, Peter Verlander, Raju Kucherlapati, Matthew Meyerson, Daniel A. Haber, Bruce E. Johnson and Thomas J. Lynch
    Clin Cancer Res July 15 2006 12 (14) 4403s-4408s; DOI:10.1158/1078-0432.CCR-06-0099

  • Novel Agents in the Treatment of Lung Cancer: Advances in EGFR-Targeted Agents
    Selecting Lung Cancer Patients for Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors by Immunohistochemistry and Fluorescence In situ Hybridization—Why, When, and How?
    Rafal Dziadziuszko, Fred R. Hirsch, Marileila Varella-Garcia and Paul A. Bunn Jr.
    Clin Cancer Res July 15 2006 12 (14) 4409s-4415s; DOI:10.1158/1078-0432.CCR-06-0087

  • Novel Agents in the Treatment of Lung Cancer: Advances in EGFR-Targeted Agents
    Effect of Epidermal Growth Factor Receptor Tyrosine Kinase Domain Mutations on the Outcome of Patients with Non–Small Cell Lung Cancer Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
    Pasi A. Jänne and Bruce E. Johnson
    Clin Cancer Res July 15 2006 12 (14) 4416s-4420s; DOI:10.1158/1078-0432.CCR-06-0555

  • Novel Agents in the Treatment of Lung Cancer: Advances in EGFR-Targeted Agents
    Combining Targeted Agents: Blocking the Epidermal Growth Factor and Vascular Endothelial Growth Factor Pathways
    Alan Sandler and Roy Herbst
    Clin Cancer Res July 15 2006 12 (14) 4421s-4425s; DOI:10.1158/1078-0432.CCR-06-0796

  • Novel Agents in the Treatment of Lung Cancer: Advances in EGFR-Targeted Agents
    Strategies to Enhance Epidermal Growth Factor Inhibition: Targeting the Mevalonate Pathway
    Jim Dimitroulakos, Ian A. Lorimer and Glenwood Goss
    Clin Cancer Res July 15 2006 12 (14) 4426s-4431s; DOI:10.1158/1078-0432.CCR-06-0089

  • Novel Agents in the Treatment of Lung Cancer: Advances in EGFR-Targeted Agents
    The Evolving Role of Cetuximab in Non–Small Cell Lung Cancer
    Rogerio C. Lilenbaum
    Clin Cancer Res July 15 2006 12 (14) 4432s-4435s; DOI:10.1158/1078-0432.CCR-06-0097

  • Novel Agents in the Treatment of Lung Cancer: Advances in EGFR-Targeted Agents
    Rationale for a Phase II Trial of Pertuzumab, a HER-2 Dimerization Inhibitor, in Patients with Non–Small Cell Lung Cancer
    Bruce E. Johnson and Pasi A. Jänne
    Clin Cancer Res July 15 2006 12 (14) 4436s-4440s; DOI:10.1158/1078-0432.CCR-06-0629

  • Novel Agents in the Treatment of Lung Cancer: Advances in EGFR-Targeted Agents
    Epidermal Growth Factor Receptor Inhibitors in Development for the Treatment of Non–Small Cell Lung Cancer
    John V. Heymach, Monique Nilsson, George Blumenschein, Vassiliki Papadimitrakopoulou and Roy Herbst
    Clin Cancer Res July 15 2006 12 (14) 4441s-4445s; DOI:10.1158/1078-0432.CCR-06-0286

  • Novel Agents in the Treatment of Lung Cancer: Advances in EGFR-Targeted Agents
    Novel Combinations Based on Epidermal Growth Factor Receptor Inhibition
    Alex A. Adjei
    Clin Cancer Res July 15 2006 12 (14) 4446s-4450s; DOI:10.1158/1078-0432.CCR-06-0623

  • Novel Agents in the Treatment of Lung Cancer: Advances in EGFR-Targeted Agents
    Targeted Therapies in Combination with Chemotherapy in Non–Small Cell Lung Cancer
    David H. Johnson
    Clin Cancer Res July 15 2006 12 (14) 4451s-4457s; DOI:10.1158/1078-0432.CCR-06-0095

Back to top
PreviousNext
Clinical Cancer Research: 12 (14)
July 2006
Volume 12, Issue 14
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

Issue Highlights

  • Chronic Oxaliplatin Resistance Induces Epithelial-to-Mesenchymal Transition in Colorectal Cancer Cell Lines
  • c-Met Ectodomain Shedding Rate Correlates with Malignant Potential
  • Megakaryocyte Potentiation Factor Cleaved from Mesothelin Precursor Is a Useful Tumor Marker in the Serum of Patients with Mesothelioma

Jump to

  • Editorial
  • The Biology Behind
  • CCR Drug Updates
  • Molecular Pathways
  • Review
  • Human Cancer Biology
  • Imaging, Diagnosis, Prognosis
  • Cancer Therapy: Clinical
  • Cancer Therapy: Preclinical
  • Correction
  • Novel Agents in the Treatment of Lung Cancer: Advances in EGFR-Targeted Agents
Advertisement
  • Most Cited
  • Most Read
Loading
  • FLASH-RT Spares Lung Progenitor Cells
  • Toxicity Management Affects Checkpoint Inhibitor Efficacy
  • scRNA-seq Analysis of Gastric Cancer TME
  • PDAC and GATA6 Expression
  • AR Gene Rearrangements in Prostate Cancer
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement